President & CEO of Cytokinetics Inc (NASDAQ:CYTK), Blum Robert I, sells 5,000 shares worth $78,644
According to Cytokinetics Inc's most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Nov 25 04:20 PM, company President & CEO, Blum Robert I disclosed selling 5,000 shares at a cost of $15.73. At the time of this transaction (Nov 23), this trade was worth $78,644 in total. As of Nov 23, Blum Robert I now owns 304,868 shares in total worth about $5,060,808.800000001.
For the last few recent trades made by Cytokinetics Inc (NASDAQ:CYTK) President & CEO, Blum Robert I, we have the following information:
- SEC Form 4 filing: Jan 15: Sold 4,950 shares at the rate of $12.96 per share. Total worth of this trade was $64,159. Total number of shares owned as of Jan 15 were 224,107
- SEC Form 4 filing: Dec 16: Sold 6,000 shares at the rate of $10.22 per share. Total worth of this trade was $61,326. Total number of shares owned as of Dec 16 were 229,057
- SEC Form 4 filing: Nov 15: Sold 6,000 shares at the rate of $8.08 per share. Total worth of this trade was $48,508. Total number of shares owned as of Nov 15 were 235,057
Posted by
George Daniels
on Wednesday November 25 2020, 5:57 PM EDT.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
